© 2026 NervNow™. All rights reserved.
Eli Lilly Signs Up to $2.75B Deal for Insilico’s AI Drugs

Eli Lilly and Insilico Medicine announced a global licensing and research collaboration on March 29, 2026, worth up to $2.75 billion, deepening a partnership that began in 2023.













